Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Esomeprazole-Induced Central Fever with Severe Myalgia

View through CrossRef
OBJECTIVE: To report a case of central fever associated with severe myalgia following esomeprazole. CASE SUMMARY: A 64-year-old man presented with intense cephalalgia; severe, diffuse myalgia; and fever (>40°C) after esomeprazole initiation for treatment of gastritis. Five hours after ingestion of the first esomeprazole pill (40 mg), the patient developed fever associated with cephalalgia and myalgia. This condition lasted about 40 hours and disappeared spontaneously. Symptoms partially responded to acetaminophen. Four days later, the patient received a second dose of esomeprazole 40 mg. Subsequently, 4 hours later, fever (>40°C), headache, and difficulty in the movement of all parts of the body recurred. Neurologic examination was negative except for a minor state of disorientation. All reflexes were normal or slightly decreased. No skin lesions or breathing difficulty was noted. Routine blood tests were normal. Again, symptoms resolved spontaneously about 40 hours later. DISCUSSION: The temporal connection between esomeprazole intake and the onset of fever suggests a probable causal link, as confirmed by the Naranjo probability scale. However, the pathogenic mechanism remains unclear. Considering that esomeprazole is able to cross the blood—brain barrier, its peak serum concentration is reached 90–180 minutes after oral administration, and its serum half-life is approximately 2 hours, we assume that the appearance of fever with accompanying neurologic and muscular symptoms might result from the drug interference with the hypothalamic regulatory center of body temperature. CONCLUSIONS: Hyperpyrexia of central origin associated with intense cephalalgia and myalgia may occur as an adverse effect of esomeprazole therapy.
Title: Esomeprazole-Induced Central Fever with Severe Myalgia
Description:
OBJECTIVE: To report a case of central fever associated with severe myalgia following esomeprazole.
CASE SUMMARY: A 64-year-old man presented with intense cephalalgia; severe, diffuse myalgia; and fever (>40°C) after esomeprazole initiation for treatment of gastritis.
Five hours after ingestion of the first esomeprazole pill (40 mg), the patient developed fever associated with cephalalgia and myalgia.
This condition lasted about 40 hours and disappeared spontaneously.
Symptoms partially responded to acetaminophen.
Four days later, the patient received a second dose of esomeprazole 40 mg.
Subsequently, 4 hours later, fever (>40°C), headache, and difficulty in the movement of all parts of the body recurred.
Neurologic examination was negative except for a minor state of disorientation.
All reflexes were normal or slightly decreased.
No skin lesions or breathing difficulty was noted.
Routine blood tests were normal.
Again, symptoms resolved spontaneously about 40 hours later.
DISCUSSION: The temporal connection between esomeprazole intake and the onset of fever suggests a probable causal link, as confirmed by the Naranjo probability scale.
However, the pathogenic mechanism remains unclear.
Considering that esomeprazole is able to cross the blood—brain barrier, its peak serum concentration is reached 90–180 minutes after oral administration, and its serum half-life is approximately 2 hours, we assume that the appearance of fever with accompanying neurologic and muscular symptoms might result from the drug interference with the hypothalamic regulatory center of body temperature.
CONCLUSIONS: Hyperpyrexia of central origin associated with intense cephalalgia and myalgia may occur as an adverse effect of esomeprazole therapy.

Related Results

Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
(1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and me...
A Novel Analytical approach for Simultaneous Estimation of Esomeprazole and Ondansetron by HPLC-DAD Method with Degradation Studies
A Novel Analytical approach for Simultaneous Estimation of Esomeprazole and Ondansetron by HPLC-DAD Method with Degradation Studies
Objective: A simultaneous estimation of Esomeprazole and Ondansetron by HPLC-DAD method with degradation studies was developed. Method: It was carried out using Kromasil (150mm×4.6...
Aetiology of fever in patients with acute stroke *
Aetiology of fever in patients with acute stroke *
Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K (University of Athens School of Medicine, ‘Alexandra’ Hospital, Athens, Greece; Harvard School of Public Health, Boston...
Feverish: Self-Induced Fever and the Creative Mind
Feverish: Self-Induced Fever and the Creative Mind
<p>This thesis is a hybrid work that combines the critical and creative components of the Creative Writing PhD in a novel, Feverish. It includes notes, an afterword, and a fu...
Clinical Efficacy of Dexlansoprazole vs Esomeprazole in Gastro-Oesophageal Reflux Disease: A Randomized Clinical Trial.
Clinical Efficacy of Dexlansoprazole vs Esomeprazole in Gastro-Oesophageal Reflux Disease: A Randomized Clinical Trial.
Background: Gastro-Esophageal reflux disease (GERD) is a very common problem in a gastrointestinal clinical setting. Still, the best treatment for it remains debatable as there are...

Back to Top